Top advances of the year: Cervical cancer
Cancer · 2024-08 · 130 (15) · 2571-2576
DOI: 10.1002/cncr.35334 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer, online erschienen am 23.04.2024. Verfasst von Linda R Duska und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Virginia School of Medicine, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Immunotherapy. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The year 2023 was an extraordinary year for the further development and expansion of novel treatments for all patients with cervical cancer, ranging from early stage to later stage and metastatic or recurrent disease. Individuals with early‐stage disease will benefit from less invasive surgery with subsequent improvement in quality of life. The effectiveness of immunotherapy has been demonstrated in upfront, locally advanced cervical cancer and confirmed in advanced metastatic disease. Induction chemotherapy will play a role in some patients with locally advanced disease, particularly those in low resource areas of the world. Novel therapeutics including antibody–drug conjugates have shown efficacy even in pretreated patients. As we continue to explore innovative therapeutics in this space, however, we must also continue to improve the diversity of clinical trial accrual to allow for generalizable results. At the same time, we must focus on eradicating this disease with appropriate screening and vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Virginia School of Medicine, Charlottesville, Virginia, USA.
- Massey Comprehensive Cancer Center, VCUHealth, Richmond, Virginia, USA.
ORCID-Profile: Linda R Duska, Sarah E Podwika
Zitieren
APA
Duska, L. R., Podwika, S. E., & Randall, L. M. (2024). Top advances of the year: Cervical cancer. Cancer, 130(15), 2571-2576. https://doi.org/10.1002/cncr.35334
Vancouver
Duska LR, Podwika SE, Randall LM. Top advances of the year: Cervical cancer. Cancer. 2024;130(15):2571-2576. doi:10.1002/cncr.35334
BibTeX
@article{Duska2024,
author = {Duska, Linda R and Podwika, Sarah E and Randall, Leslie M},
title = {Top advances of the year: Cervical cancer},
journal = {Cancer},
year = {2024},
volume = {130},
number = {15},
pages = {2571--2576},
doi = {10.1002/cncr.35334}
}
EUVIMED